mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.048 |
0.4 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.4 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.4 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |